Novartis AG announced today it completed the acquisition of Amblyotech, which uses gaming and video technology with 3-D glasses to train the eyes of people with amblyopia, commonly known as lazy eye, to work properly.
The Swiss pharma company did not disclose financial details, but said it acquired the US start-up to start a proof-of-concept...
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?